WHO Advises Against The Use Of Antibiotics For COVID-19 Patients
The World Health Organisation (WHO) has advised against the use of antibiotics even in patients with severe COVID when a concurrent bacterial infection is not suspected.
The global health body has released updated recommendations for the clinical management of people with COVID, which, it said, are based on evidence generated from a recent meta-analysis of outcomes of patients treated with antibiotics for the virus.
"For patients with non-severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we recommend no empirical antibiotics. For patients with severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we suggest no empirical antibiotics," the WHO said.
The WHO said that, as COVID-19 epidemiology and severity have changed, and as emergency measures have subsided, the evidence behind a number of recommendations has changed.
In parallel, the evolution of health systems and the global environment has meant that the recommendations are implemented in a very different context in 2024 compared to 2020.
These guidelines have evolved from the first version in 2020 in line with new information and changing circumstances of the pandemic, the WHO said.
"Notable changes to COVID-19 disease over this time have been overall reduced infection rates and reduced disease severity. Emergency measures which were imposed have also been removed, and care for patients with COVID-19 has become more integrated with usual healthcare systems.
"This different environment has prompted a review of the scope and content of all existing guidance. In order to maintain a clear focus and relevance, we have removed recommendations which would be considered general medical principles, and those which are no longer specific to the management of COVID-19," the WHO said.
The new recommendations on the use of antibiotics were prompted by the publication of data from a systematic review and meta-analysis, and the pressing need to address antimicrobial resistance.
The WHO said the updated guidelines are for people directly or indirectly involved in the health care of patients with COVID-19 and post-COVID-19 conditions. This includes clinicians, allied health care workers, facility managers, and hospital administrators.
The SARS-CoV-2 continues to infect several thousand people daily, leading to preventable morbidity and mortality across the world, the WHO said.
The roll-out of vaccines and treatment for COVID-19, and increasing population immunity from infection, has substantially reduced hospitalization, severity of disease, and mortality.
"However, the virus continues to evolve in terms of infectivity, immune escape, and disease severity. This guideline robustly and transparently addresses the changing landscape and evidence availability, and the continual development of treatment and management strategies for COVID-19," the WHO stated.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
39 minutes ago
- News18
Mizoram: 39 people tested positive for COVID-19 so far in 2025
Agency: Aizawl, Aug 10 (PTI) Thirty-nine people have tested positive for COVID-19 in Mizoram so far this year, officials said on Sunday. Of them, 28 people have recovered from the infection. According to the Integrated Disease Surveillance Programme (IDSP), 11 people are currently undergoing treatment for COVID-19. All of them are from the Aizawl district Twenty-seven suspected patients were tested on August 8, and one of them was found positive for the infection. On August 5, 10 people tested positive for COVID-19. They are out of danger, officials said. PTI CORR SOM First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
3 hours ago
- Time of India
Indian-origin Dr Vinay Prasad returns to FDA weeks after exit; Laura Loomer calls it 'egregious decision'
Dr Vinay Prasad is back at his FDA job weeks after exit that was prompted by right-wing activist Laura Loomer's campaigning against Prasad. Dr Vinay Prasad, the Indian-origin vaccine chief of the FDA who was forced to resign in July after far-right activist Laura Loomer led a campaign against him, has been reinstated to his job in an unusual instance. Laura Loomer pointed out the critical comments that Dr Prasad made about President Donald Trump before joining the administration, while some of his decisions to deny drug approvals also came under fire. A Department of Health and Human Services spokesperson confirmed to the New York Times that Dr Prasad is returning to the agency. 'At the F.D.A.'s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' Andrew Nixon, a health department spokesman, said in a statement. The NYT report observed that Dr Prasad's rehiring suggests that the health secretary, Robert F Kennedy Jr., and the FDA commissioner, Dr Marty Makary, remain influential enough in the Trump administration to employ someone who had previously expressed disdain for Trump and his followers. Loomer reacted to the reinstatement and called in another "egregious personnel decision". "In another egregious personnel decision under the Trump administration, it is now being reported that longtime progressive Marxist Vinay Prasad who referred to President Trump's supporters as criminals and compared them to drug addicts after saying he stabbed a Trump voodoo doll to 'curse Trump' is apparently back at FDA," Loomer wrote. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Everyone is suddenly using this AI language learning app Talkpal AI Learn More Undo RFK Jr tapped Dr Prasad in May when the previous head of the FDA's Center for Biologics Evaluation left the role. During the Covid-19 pandemic, Dr Prasad gained prominence as an outspoken critic of vaccines and mask mandate. In his short stint at the FDA since May, Dr Prasad limited the use of Covid-19 vaccines and promoted warnings about a rare side effect of the vaccines. When he resigned from his role weeks ago, a department spokesperson told the NYT: "Dr. Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with his family." Kennedy, however, opposed Prasad's departure from the role and remained invested in bringing him back. Dr Prasad was born and brought up in Ohio and Chicago to Indian immigrant parents.
News18
4 hours ago
- News18
China's War On Mosquitoes To Eradicate Chikungunya Revives Covid Lockdown Memories: Report
Chinese authorities have mobilised their entire health apparatus in a "war on mosquitoes" to eradicate a Chikungunya outbreak in Guangdong province. Authorities in China have launched what is believed to be a 'war on mosquitoes" to eradicate a growing outbreak of the Chikungunya virus in Guangdong province. The country's health apparatus has mobilised in a way not seen since the mass lockdowns during the Covid-19 pandemic. The campaign involves drones and even other predatory creatures to eliminate mosquitoes and fumigators are searching every village, reflecting the seriousness of the Chinese government in this endeavour. Officials in Guangdong have reported more than 7,000 cases of the virus since last month, according to the Financial Times. The outbreak is primarily concentrated in Foshan, a major manufacturing city home to approximately 9 million people, but officials have located cases in Hong Kong, Macau and the neighbouring Hunan province. While Chikungunya is rarely fatal and authorities have not reported any deaths from the ongoing outbreak, the Chinese government has sprung into action to contain the disease by conducting regular fumigation and entering homes to check for stagnant water in which mosquitoes can breed. Officials in the Guangdong province are even breeding sites with drones and are introducing carp species and the larvae of giant mosquitoes, which eat mosquitoes that carry the chikungunya virus. As part of public awareness measues, red-and-yellow banners can be seen in Tengchong, bearing rhyming slogans that remind residents of the dangers of stagnant water and mosquitoes. Last week, provincial governor Wang Weizhong reportedly called on officials to encourage residents to light mosquito coils, install gauze netting and apply bug spray as part of a 'patriotic health campaign" to prevent the spread of the virus. Why Is It Being Compared To Covid-19? However, China's relentless campaign against mosquitoes has been compared to its extreme efforts to control the Covid-19 pandemic, notably by officials in Foshan instructing pharmacies to record the names of customers buying medicines for Chikungunya symptoms like rashes, joint pain and fevers. Two cities in the neighbouring Fujian province have issued reminders to visitors from Foshan to undergo 14 days of self-monitoring, FT reported citing state media. Medics in at least one affected area are registering the details of infected individuals with the local Communist party committee, which sends them to a special 'quarantine" hospital wards in which patients are separated by gauze netting, according to a health worker. Residents are tested via nucleic acid testing, sometimes conducted by health workers under temporary outdoor shelters that evoke memories of Covid-19 mass swabbing sites. A patient's stay in the quarantine hospital is dependent on these tests. However, some citizens have welcomed these steps. 'I hope the government can continue to implement all of these measures and keep exterminating mosquitoes frequently, so that we don't have to deal with the trouble that they bring," said Liu, a Tengchong resident who made a full recovery after contracting Chikungunya. view comments Location : Beijing, China First Published: August 10, 2025, 17:20 IST News world China's War On Mosquitoes To Eradicate Chikungunya Revives Covid Lockdown Memories: Report Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
